Share on StockTwits

AstraZeneca plc (LON:AZN)‘s stock had its “hold” rating reissued by stock analysts at Beaufort Securities in a report issued on Thursday.

AstraZeneca plc (LON:AZN) opened at 4375.50 on Thursday. AstraZeneca plc has a 52 week low of GBX 3086.50 and a 52 week high of GBX 5750.00. The stock’s 50-day moving average is GBX 4311.87 and its 200-day moving average is GBX 4206.58. The company’s market cap is £55.263 billion.

A number of other firms have also recently commented on AZN. Analysts at Deutsche Bank reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Thursday. They now have a GBX 4,000 ($66.87) price target on the stock. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Wednesday. They now have a GBX 4,500 ($75.23) price target on the stock. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of AstraZeneca plc in a research note on Thursday, August 14th. They now have a GBX 4,800 ($80.24) price target on the stock. Six research analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and six have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of GBX 4,055.48 ($67.79).

AstraZeneca PLC (LON:AZN) is a global biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.